Catalyst Pharmaceuticals Inc

The Patient Access Liaison (PAL) provides clinical disease state education and product education to patients and their families, working closely with various stakeholders to address barriers to access. The PAL also coordinates communication among key stakeholders and maintains ongoing contact with patients to ensure they receive the necessary support.

Provide clinical disease state and product education to patients and families to ensure optimal understanding of rare disease medicines. Coordinate with physicians, HUB partners, and insurance providers to remove barriers to therapy access and affordability.

The Patient Access Liaison (PAL) provides clinical disease state education and product education to patients and their families, working closely with various stakeholders to address barriers to access. The PAL also supports advocacy for patients and ensures seamless communication with HUB partners.